Health In Tech, Inc. SEC Filings

Health In Tech, Inc. reported Q3 2025 results, showing strong growth and continued profitability. Revenue reached $8,490,093, up from $4,458,921 a year ago, while gross profit rose to $5,143,816 from $3,479,293. Operating expenses increased to $4,650,293 from $3,040,411 as the company invested in growth and platform capabilities. Net income was $452,176, compared with $376,086 in Q3 2024.

For the nine months, revenue was $25,818,926 versus $14,586,342, with net income of $1,581,399 versus $814,629, reflecting expanded SMR program fees and higher ICE underwriting revenue. Cash and cash equivalents were $8,023,613, supported by $2,682,602 provided by operating activities and offset by $2,358,213 invested in software development. The company recorded contra revenue tied to a carrier portfolio adjustment of $1,413,345 in Q3 and $2,369,088 year-to-date, with an $869,088 refund liability recorded. As of November 10, 2025, shares outstanding were 45,208,808 Class A and 11,700,000 Class B.

Health In Tech, Inc. furnished an earnings call transcript under Item 7.01. The call, held on November 10, 2025, covered financial and operating results for the quarter ended September 30, 2025. The transcript is included as Exhibit 99.1.

The information is deemed “furnished,” not “filed,” under the Exchange Act. A replay is available via the Company’s Investor Relations site through approximately February 8, 2026.

Health In Tech, Inc. (HIT) furnished an update on its quarterly results. The company reported that it issued a press release announcing results for the quarter ended September 30, 2025, and made that release available as Exhibit 99.1.

The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). The information in these items, including Exhibit 99.1, is expressly stated as “furnished” and not “filed” under the Exchange Act. The filing also includes customary forward‑looking statements language referring to risks described in the company’s periodic reports.

Health In Tech, Inc. (HIT) furnished an investor presentation under Regulation FD, making it available as Exhibit 99.1 to an 8-K. The materials are expressly deemed “furnished” and not “filed” under the Exchange Act, which means they are not subject to Section 18 liability and are not incorporated by reference into other filings. The company also included customary forward-looking statements language outlining risks referenced in prior SEC reports.

Health In Tech, Inc. (HIT) reported an insider equity award. On 11/05/2025, the company’s CISO, Michael Clarkson, received 8,000 restricted shares of Class A Common Stock coded “A” at a price of $0.00 under the Health in Tech Equity Incentive Plan. Following the grant, he beneficially owns 8,000 shares, held directly.

The restricted shares vest in equal monthly installments over twelve months, commencing on November 1, 2025, contingent on continued service through each vesting date. This filing reflects routine equity compensation for an officer rather than an open‑market transaction.

Health In Tech (HIT) disclosed an initial insider ownership filing on Form 3 for Michael Clarkson, the company’s CISO. The filing states that no securities are beneficially owned by the reporting person as of the event date 11/01/2025.

The Form 3 was filed by one reporting person in the capacity of an officer. No non-derivative or derivative holdings were reported.

Insider transactions by director William D. Howard at Health In Tech, Inc. (HIT)

The reporting person, a director, disposed of 28,159 restricted shares of Class A common stock that were subject to pro-rata forfeiture upon the annual stockholders meeting held on 10/03/2025. Five days later, on 10/08/2025, the director acquired 5,730 restricted shares at a price of $3.49 per share under the company’s Equity Incentive Plan. After these transactions the director beneficially owns 106,045 shares of Class A common stock.

Insider transactions by Director Timothy Hayes at Health In Tech, Inc. (HIT)

Director Timothy Hayes reported a disposition and a later acquisition of Class A common stock. On 10/03/2025 he disposed of 28,159 restricted shares that were forfeitable pro rata at the issuer's annual meeting, leaving 100,315 shares beneficially owned. On 10/08/2025 he acquired 5,730 restricted shares at a purchase price of $3.49 per share; those newly granted restricted shares vest quarterly from the grant date subject to continued service. The filing shows Hayes remains a significant insider and that his post-transaction holdings total 106,045 shares, combining previously owned and newly granted restricted stock.

Insider transactions by Director Sanjay K. Shrestha at Health In Tech, Inc. (HIT). The form reports a disposition of 65,469 Class A common shares on 10/03/2025 that were restricted shares subject to forfeiture tied to the annual stockholders meeting. The filing also shows an acquisition of 5,730 restricted Class A shares on 10/08/2025 at a purchase price of $3.49 per share; those restricted shares vest quarterly from the grant date with continued service. After these transactions the reporting person beneficially owned 68,735 Class A shares on a direct basis.